Aurobindo Pharma

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE406A01037
  • NSEID: AUROPHARMA
  • BSEID: 524804
INR
1,222.00
-1.65 (-0.13%)
BSENSE

Dec 05

BSE+NSE Vol: 99.89 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
Net Sales
31,723.73
29,001.87
24,855.38
23,455.49
24,774.63
23,098.50
19,563.55
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
31,723.73
29,001.87
24,855.38
23,455.49
24,774.63
23,098.50
19,563.55
Raw Material Cost
10,736.76
10,776.14
9,652.51
7,371.83
8,317.27
7,724.98
7,444.99
Purchase of Finished goods
2,887.11
2,772.93
2,050.43
1,951.77
2,315.42
2,112.11
1,943.20
(Increase) / Decrease In Stocks
-597.63
-946.17
-409.68
816.68
-730.21
-101.86
-675.55
Employee Cost
4,475.62
3,922.94
3,522.25
3,450.92
3,535.02
3,219.18
2,584.87
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
7,639.08
6,633.03
6,321.23
5,477.52
6,003.72
5,319.49
4,374.38
Total Expenditure (Excl Depreciation)
25,140.94
23,158.87
21,136.74
19,068.72
19,441.22
18,273.90
15,671.89
Operating Profit (PBDIT) excl Other Income
6,582.79
5,843.00
3,718.64
4,386.77
5,333.41
4,824.60
3,891.66
Other Income
621.85
557.38
290.59
320.35
380.84
86.20
115.66
Operating Profit (PBDIT)
7,204.64
6,400.38
4,009.23
4,707.12
5,714.25
4,910.80
4,007.32
Interest
457.24
289.71
140.48
48.64
74.49
159.77
162.66
Exceptional Items
0.00
-191.86
0.00
-127.97
2,814.58
-26.13
-88.06
Gross Profit (PBDT)
6,747.40
5,918.81
3,868.75
4,530.51
8,454.34
4,724.90
3,756.60
Depreciation
1,649.42
1,521.66
1,244.58
1,126.52
1,055.38
966.71
667.95
Profit Before Tax
5,097.98
4,397.15
2,624.17
3,403.99
7,398.96
3,758.19
3,088.65
Tax
1,582.72
1,211.02
684.85
725.63
2,009.77
913.51
726.85
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
3,515.26
3,186.13
1,939.32
2,678.36
5,389.19
2,844.68
2,361.80
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
3,515.26
3,186.13
1,939.32
2,678.36
5,389.19
2,844.68
2,361.80
Share in Profit of Associates
-31.69
-17.16
-11.67
-31.25
-55.36
-15.17
2.70
Minority Interest
2.31
4.00
-0.15
1.04
1.02
1.46
0.23
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
3,485.88
3,172.97
1,927.50
2,648.15
5,334.85
2,830.97
2,364.73
Equity Capital
58.08
58.59
58.59
58.59
58.59
58.59
58.59
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
32,595.24
29,784.21
26,781.26
24,517.39
21,871.27
16,766.07
13,832.19
Earnings per share (EPS)
60.02
54.16
32.9
45.2
91.05
48.32
40.36
Diluted Earnings per share
59.81
54.16
32.9
45.19
91.04
48.32
40.36
Operating Profit Margin (Excl OI)
20.98%
20.36%
15.11%
18.77%
21.72%
21.22%
20.24%
Gross Profit Margin
21.5%
20.62%
15.72%
19.39%
34.43%
20.78%
19.54%
PAT Margin
11.1%
11.04%
7.83%
11.33%
21.72%
12.44%
12.3%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 9.39% vs 16.68% in Mar 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Mar 2025 is 9.86% vs 64.62% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 12.66% vs 57.13% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 57.83% vs 106.23% in Mar 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Mar 2025 has improved from Mar 2024

Compare Annual Results Of Aurobindo Pharma With
Markets Mojo
Figures in Cr
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
31,723.73
12,207.44
19,516.29
159.87%
Other Operating Income
0.00
0.00
0.00
Total Operating income
31,723.73
12,207.44
19,516.29
159.87%
Raw Material Cost
10,736.76
2,016.35
8,720.41
432.48%
Purchase of Finished goods
2,887.11
1,655.69
1,231.42
74.38%
(Increase) / Decrease In Stocks
-597.63
-183.00
-414.63
-226.57%
Employee Cost
4,475.62
2,692.37
1,783.25
66.23%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
7,639.08
3,008.10
4,630.98
153.95%
Total Expenditure (Excl Depreciation)
25,140.94
9,189.51
15,951.43
173.58%
Operating Profit (PBDIT) excl Other Income
6,582.79
3,017.93
3,564.86
118.12%
Other Income
621.85
536.79
85.06
15.85%
Operating Profit (PBDIT)
7,204.64
3,554.72
3,649.92
102.68%
Interest
457.24
429.41
27.83
6.48%
Exceptional Items
0.00
4.53
-4.53
-100.00%
Gross Profit (PBDT)
6,747.40
3,125.31
3,622.09
115.90%
Depreciation
1,649.42
621.22
1,028.20
165.51%
Profit Before Tax
5,097.98
2,504.09
2,593.89
103.59%
Tax
1,582.72
509.74
1,072.98
210.50%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
3,515.26
1,994.35
1,520.91
76.26%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
4.53
-4.53
-100.00%
Net Profit
3,515.26
1,998.88
1,516.38
75.86%
Share in Profit of Associates
-31.69
12.24
-43.93
-358.91%
Minority Interest
2.31
-20.16
22.47
111.46%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
3,485.88
1,990.96
1,494.92
75.09%
Equity Capital
58.08
41.26
16.82
40.77%
Face Value
1.00
1.00
0.00
Reserves
32,595.24
14,291.13
18,304.11
128.08%
Earnings per share (EPS)
60.02
48.25
11.77
24.39%
Diluted Earnings per share
59.81
49.19
10.62
21.59%
Operating Profit Margin (Excl OI)
20.98%
24.72%
0.00
-3.74%
Gross Profit Margin
21.50%
25.60%
0.00
-4.10%
PAT Margin
11.10%
16.44%
0.00
-5.34%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 31,723.73 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 9.39% vs 16.68% in Mar 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 3,485.88 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 9.86% vs 64.62% in Mar 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6,582.79 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 12.66% vs 57.13% in Mar 2024

Annual - Interest
Interest 457.24 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 57.83% vs 106.23% in Mar 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.98%
in Mar 2025

Figures in %
stock-summary

YoY Growth in year ended Mar 2025 has improved from Mar 2024